F. Hoffmann-La Roche AG
F. Hoffmann-La Roche AG, commonly known as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, boasting a robust portfolio of core products, including groundbreaking biologics and diagnostic tools. The company’s unique approach to integrating pharmaceuticals and diagnostics sets it apart in the market, enabling tailored treatment options for patients. Roche's notable achievements include being consistently ranked among the top pharmaceutical companies worldwide, reflecting its dedication to advancing healthcare and improving patient outcomes.
DitchCarbon Score
How does F. Hoffmann-La Roche AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
F. Hoffmann-La Roche AG's score of 78 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
F. Hoffmann-La Roche AG's reported carbon emissions
In 2016, F. Hoffmann-La Roche AG reported significant carbon emissions, totalling approximately 326,001,000 kg CO2e for Scope 1, 320,860,000 kg CO2e for Scope 2 (market-based), and 209,660,000 kg CO2e for Scope 3 emissions, which included business travel and waste generated in operations. The company has set a mid-term goal to reduce energy consumption from Scope 1 and Scope 2 sources per employee by 15% within its facilities by 2025, reflecting its commitment to improving energy efficiency and reducing its carbon footprint. As a current subsidiary of Roche Holding AG, F. Hoffmann-La Roche AG's climate initiatives and targets are aligned with those of its parent company. However, specific SBTi (Science Based Targets initiative) reduction targets have not been disclosed. The company is actively working towards enhancing its sustainability practices, although detailed emissions data for 2023 is not available. Overall, Roche's commitment to reducing emissions and improving energy efficiency demonstrates its proactive approach to addressing climate change and contributing to a more sustainable future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,214,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
F. Hoffmann-La Roche AG is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
